Category: Business Intelligence

While 2022 was the year of AI image generators and ChatGPT, 2023 was the year generative AI (genAI) exploded and captivated our imaginations. In 2024, the focus shifted from dazzling demonstrations to practical advancements. Models became incrementally more accurate, cost-effective, and multimodal, and enterprises began to commit to this technology.  While 60% of enterprise generative…

Read More “Generative AI in 2024: Bridging Imagination and Implementation” »

Following the death of a young investment banker earlier this year, C-suite leaders at top investment banks have implemented new measures to cap junior banker work hours. Junior banking roles are well known across the industry to often exceed 100 hours a week in grueling, cut-throat conditions, especially during pivotal deal periods.  In recent times,…

Read More “The Toll of Analyst Burnout” »

With artificial intelligence (AI) revolutionizing every industry, new forms of intelligence have emerged: real-world data (RWD) and real-world evidence (RWE). Within the healthcare space, these developments are driving major investments from large-scale pharmaceutical companies and health organizations. But what are RWD and RWE, exactly? Real-world data is data relating to patient health status and the…

Read More “Real-World Data: Use Cases and Challenges” »

As an AI researcher, I’m constantly looking for ways to stay ahead. Generative AI has become an essential part of my toolkit—not just because it’s faster and more flexible, but because it allows me to explore the future in ways that were previously impossible. While traditional research methods remain indispensable for deep dives, the fusion…

Read More “Leveraging Generative AI to Transform your Research” »

Generative AI has reshaped industries in recent years, but for many, the challenge persists: the insights produced are only as good as the data available, which can be inconsistent or incomplete, often leading to more questions than answers. AlphaSense addresses this head-on with a generative AI suite purpose-built for market intelligence, integrating the highest-quality data…

Read More “The Power of AlphaSense Generative AI for Market Intelligence: Revolutionizing Research with Trusted Insights” »

Generative artificial intelligence (genAI)—it’s seemingly ubiquitous, from its ascending market evaluation (reaching a $1.3 trillion by 2032 according to Bloomberg), to its proposed applications in nearly every industry (i.e., consulting, manufacturing, financial services, etc.) to its potential limitations. And while these discussions have been integral to understanding the importance of this iteration of AI today…

Read More “Generative AI in Market Intelligence: ROI Analysis” »

The success of mergers and acquisitions (M&A) heavily depends on a deep understanding of the target company, which can’t always be achieved through company reports or mentions in the news. Industry nuances, company culture, leadership styles, competitor interactions—these are facets you can’t necessarily uncover by researching numbers and figures, yet they significantly impact whether or…

Read More “6 Ways Expert Calls Lead to Successful M&A” »

Generative artificial intelligence (genAI) is gaining traction within the financial services, wealth management, and banking sectors. As the demand for instant insights and time savings grows, leading firms are recognizing the immense potential of generative AI to transform their operations and decision-making processes. From automating data analysis and forecasting to generating personalized investment recommendations, this…

Read More “Use Cases, Benefits, and Risks” »

When conducting market research in the healthcare and pharma sectors, you need access to the right information, as well as a way to separate relevant insights from extraneous noise. Maintaining a competitive advantage necessitates being the first to know of regulatory activities, new drug approvals, clinical trial pipelines, disease landscapes, BD&L, and commercialization decisions.  Unfortunately,…

Read More “Top Challenges in Healthcare and Pharma Market Research” »

Biosimilar medicines, a nearly identical copy of original biologic treatments, have recently taken center stage in the pharma industry. As approvals and implementation of biosimilar products, therapies, and medicines continue to accelerate, the U.S. healthcare system is set to experience enormous cost cuts and save Americans millions of dollars in life-essential care.  The financial burden…

Read More “The Booming Market of Biosimilars” »